Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_00634 |
| Species: | Homo sapiens |
| Position : | chr17:73746447-73746564 |
| Year: | 2014 |
| Title: | Transcriptional regulation of human ferredoxin reductase through an intronic enhancer in steroidogenic cells |
| Genome Build: | hg19 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 24321386 |
| MONDO: | |
| Tissue: | Pancreatic islet |
| Tissue Ontology ID: | UBERON:0000006 |
| Cell Source: | Islet |
| CVCL ID: | |
| Cell Type: | pancreatic islet cell |
| Cell Ontology ID: | CL:0000168 |
| Experiment Type: | Enhancer activity assay |
| High Throughput Method: | ChIP-seq |
| Low Throughput Method: | Luciferase Reporter Assay, ChIP-RT-qPCR, RT-RT-qPCR |
| Target gene : | FDXR |
| TF name : | NR5A1 |
| Regulatory State : | Active |
| GeneName | Pathway Name | Source | Gene Number |
|---|---|---|---|
| NR5A1 | Nuclear Receptor transcription pathway | reactome | 51 |
| NR5A1 | Transcriptional regulation of pluripotent stem cells | reactome | 28 |